Carbapenem-resistant Enterobacteriaceae Testing Market Insight, Size, Share, Growth, Up-To-Date Key Trends, Regional Outlook, and Forecast - 2030
| Price : US$ 3,000 | Date : Dec 2022 |
| Category : Healthcare and Pharmaceuticals | Pages : 115 |
Carbapenem Market 2020 By Manufacturers, Regions, Type, And Application, Forecast To 2026
- Code : SMI26498
- Pages : 117
- Date : Mar, 2020
- Category : Healthcare and Pharmaceuticals
- Publisher : SMI
- Format :
Summary
The global Carbapenem Market is expected to witness a CAGR of xx% over the forecast period 2020-2026 and is expected to reach US$ xx million in 2026, from US$ xx million in 2019.
Carbapenems are a class of beta-lactam antibiotic that are active against many aerobic and anaerobic gram-positive and gram-negative organisms. This antibiotic is used for the treatment of intra-abdominal infections, complicated urinary tract infections, pneumonia, and bloodstream infections.
High prevalence of intra-abdominal infections is expected to propel growth of the global carbapenem market over the forecast period. For instance, according to an observational epidemiological study of intra-abdominal infections published in December 2019, in NEJM Journal Watch, of the 2621 critically ill adults with intra-abdominal infections at 309 international centers between January and December 2016, 32% were community-acquired, while 68% were hospital-acquired.
Investment for R&D in carbapenem resistance is expected to offer lucrative growth opportunities for players in the global carbapenem market. For instance, in September 2020, Curetis AG, a subsidiary of OpGen, received over US$ 410,000 from the Federal German Ministry of Education and Research to use artificial intelligence for developing a test for carbapenem resistance in Gram-negative bacteria.
However, overuse and misuse of antibiotics leads to a rise in antibiotic resistance, which is expected to hinder growth of the global carbapenem market over the forecast period. High incidence of carbapenem-resistant acinetobacter that causes pneumonia and wound, bloodstream, and urinary tract infections is also expected to limit the market growth over the forecast period. For instance, in June 2018, European Centre for Disease Prevention and Control in a Rapid Risk Assessment stated that infections with bacteria resistant to carbapenems pose a significant threat to patients and healthcare systems in all EU/EEA countries.
Key Takeaways
- High incidence of community-acquired pneumonia is expected to propel growth of the global carbapenem market over the forecast period. For instance, according to the study, ‘Seasonal Incidence of Community-acquired Pneumonia: A Retrospective Study in a Tertiary Care Hospital in Kathmandu, Nepal’, published in December 2019, an incidence of sputum-positive community-acquired pneumonia was found in 13.4% of the cases.
- Major players operating in the global carbapenem market are focused on offering GMP products to enhance their market share. For instance, in June 2018, Asymchem, an APIs manufacturing company, announced that its dedicated carbapenem manufacturing Fuxin 1 Chinese site passed the U.S. Food and Drug Administration's general GMP reinspection to meet the highest quality standards in the manufacturing of GMP products.
- Major players operating in the global carbapenem market include, Pfizer, Inc., Asymchem, Savior Lifetec, Sun Pharmaceutical Industries, Kopran, HISUN Pharmaceutical, Haibin Pharmaceutical, and United Lab
The Carbapenem Market report highlights product development and growth strategies such as merger and acquisition adopted by market players along with SWOT Analysis, PEST and Porter’s Five Forces analyses of the Carbapenem Market, which highlight the strengths, weaknesses, opportunities, and commination of key companies. Moreover, the report offers two distinct market forecasts, one from the perspective of the producer and another from that of the consumer.
The various contributors involved in the value chain of the product include manufacturers, suppliers, distributors, intermediaries, and customers.
The Key Manufacturers covered in this Report:-
- Pfizer
- Savior Lifetec
- Sun Pharmaceutical Industries
- Kopran
- HISUN Pharmaceutical
- Haibin Pharmaceutical
- United Lab
- ...
By the Product Type, the market is primarily segmented into:
- Meropenem
- Doripenem
- Imipenem
- Panipenem
- Others
By Applications, the market is segmented into:
- Hosptials
- Clinics
- Others
The Report covers the following Regions:
- North America
- United States
- Canada
- Mexico
- Asia Pacific
- China
- Japan
- South Korea
- India
- Australia
- Indonesia
- Thailand
- Malaysia
- Philippines
- Vietnam
- Europe
- Germany
- France
- UK
- Italy
- Russia
- Central & South America
- Brazil
- Middle East & Africa
- Turkey
- GCC Countries
- Egypt
- South Africa
Objective of the Carbapenem Market Report:
- To assess the size of the market by value and volume
- Analyze the Carbapenem Market in terms of regions and major countries
- Highlight recent developments and trends in the market
- Offer perceptive data regarding major market players in terms of key developments, strategies, and product portfolio
- Determine share of the Carbapenem Market in terms of various segments such as by product type, application, and end-user
- Offer accurate projection of the market for the forecast period using state-of –the-art tools and the current primary and secondary research approaches
- Discuss major factors that impact growth of the Carbapenem Market
The Carbapenem Market engages the readers with all pivotal approaches to understand their position in the industry based on revenue or sales growth. The report efficiently evaluates the Carbapenem Market from various dimensions to deliver an end-product that is informative, elaborate, and accurate and includes detailed market segmentation, regional analysis, and competition in the market. The information in the report is backed by annual company reports, financial reports, press releases, regulatory databases, government documents, and statistical databases.
For the data information by region, company, type and application, 2019 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.
Key Stakeholders:
- Material suppliers/wholesalers
- Market Distributors/traders
- Regulatory bodies
- Research organizations, and consulting firms
- Commercial research & developments (R&D)
- Trade associations and industry bodies
- Importers and exporters
- End-use industries
Available Customizations:
Custom research is one of the most crucial components of the business strategy that helps an organization gain insight into specific business sector, aligned with its specific area of interest. Thus, SMI offers more accurate, pragmatic, and actionable information specifically tailored to suit your business needs.
Table of Contents
1 Study Coverage
1.1 Carbapenem Product Introduction
1.2 Market Segments
1.3 Key Manufacturers Covered
1.4 Market by Type
1.4.1 Global Carbapenem Market Size Growth Rate by Type
1.4.2 Meropenem
1.4.3 Doripenem
1.4.4 Imipenem
1.4.5 Panipenem
1.4.6 Others
1.5 Market by Application
1.5.1 Global Carbapenem Market Size Growth Rate by Application
1.5.2 Hosptials
1.5.3 Clinics
1.5.4 Others
1.6 Study Objectives
1.7 Years Considered
2 Executive Summary
2.1 Global Carbapenem Market Size
2.1.1 Global Carbapenem Revenue 2014-2025
2.1.2 Global Carbapenem Sales 2014-2025
2.2 Carbapenem Growth Rate by Regions
2.2.1 Global Carbapenem Sales by Regions
2.2.2 Global Carbapenem Revenue by Regions
3 Breakdown Data by Manufacturers
3.1 Carbapenem Sales by Manufacturers
3.1.1 Carbapenem Sales by Manufacturers
3.1.2 Carbapenem Sales Market Share by Manufacturers
3.2 Carbapenem Revenue by Manufacturers
3.2.1 Carbapenem Revenue by Manufacturers (2014-2019)
3.2.2 Carbapenem Revenue Share by Manufacturers (2014-2019)
3.3 Carbapenem Price by Manufacturers
3.4 Carbapenem Manufacturing Base Distribution, Product Types
3.4.1 Carbapenem Manufacturers Manufacturing Base Distribution, Headquarters
3.4.2 Manufacturers Carbapenem Product Type
3.4.3 Date of International Manufacturers Enter into Carbapenem Market
3.5 Manufacturers Mergers & Acquisitions, Expansion Plans
4 Breakdown Data by Type
4.1 Global Carbapenem Sales by Type
4.2 Global Carbapenem Revenue by Type
4.3 Carbapenem Price by Type
5 Breakdown Data by Application
5.1 Overview
5.2 Global Carbapenem Breakdown Data by Application
6 North America
6.1 North America Carbapenem by Country
6.1.1 North America Carbapenem Sales by Country
6.1.2 North America Carbapenem Revenue by Country
6.1.3 United States
6.1.4 Canada
6.1.5 Mexico
6.2 North America Carbapenem by Type
6.3 North America Carbapenem by Application
7 Europe
7.1 Europe Carbapenem by Country
7.1.1 Europe Carbapenem Sales by Country
7.1.2 Europe Carbapenem Revenue by Country
7.1.3 Germany
7.1.4 France
7.1.5 UK
7.1.6 Italy
7.1.7 Russia
7.2 Europe Carbapenem by Type
7.3 Europe Carbapenem by Application
8 Asia Pacific
8.1 Asia Pacific Carbapenem by Region
8.1.1 Asia Pacific Carbapenem Sales by Region
8.1.2 Asia Pacific Carbapenem Revenue by Region
8.1.3 China
8.1.4 Japan
8.1.5 South Korea
8.1.6 India
8.1.7 Australia
8.1.8 Indonesia
8.1.9 Thailand
8.1.10 Malaysia
8.1.11 Philippines
8.1.12 Vietnam
8.2 Asia Pacific Carbapenem by Type
8.3 Asia Pacific Carbapenem by Application
9 Central & South America
9.1 Central & South America Carbapenem by Country
9.1.1 Central & South America Carbapenem Sales by Country
9.1.2 Central & South America Carbapenem Revenue by Country
9.1.3 Brazil
9.2 Central & South America Carbapenem by Type
9.3 Central & South America Carbapenem by Application
10 Middle East and Africa
10.1 Middle East and Africa Carbapenem by Country
10.1.1 Middle East and Africa Carbapenem Sales by Country
10.1.2 Middle East and Africa Carbapenem Revenue by Country
10.1.3 Turkey
10.1.4 GCC Countries
10.1.5 Egypt
10.1.6 South Africa
10.2 Middle East and Africa Carbapenem by Type
10.3 Middle East and Africa Carbapenem by Application
11 Company Profiles
11.1 Pfizer
11.1.1 Pfizer Company Details
11.1.2 Company Business Overview
11.1.3 Pfizer Carbapenem Sales, Revenue and Gross Margin (2014-2019)
11.1.4 Pfizer Carbapenem Products Offered
11.1.5 Pfizer Recent Development
11.2 Savior Lifetec
11.2.1 Savior Lifetec Company Details
11.2.2 Company Business Overview
11.2.3 Savior Lifetec Carbapenem Sales, Revenue and Gross Margin (2014-2019)
11.2.4 Savior Lifetec Carbapenem Products Offered
11.2.5 Savior Lifetec Recent Development
11.3 Sun Pharmaceutical Industries
11.3.1 Sun Pharmaceutical Industries Company Details
11.3.2 Company Business Overview
11.3.3 Sun Pharmaceutical Industries Carbapenem Sales, Revenue and Gross Margin (2014-2019)
11.3.4 Sun Pharmaceutical Industries Carbapenem Products Offered
11.3.5 Sun Pharmaceutical Industries Recent Development
11.4 Kopran
11.4.1 Kopran Company Details
11.4.2 Company Business Overview
11.4.3 Kopran Carbapenem Sales, Revenue and Gross Margin (2014-2019)
11.4.4 Kopran Carbapenem Products Offered
11.4.5 Kopran Recent Development
11.5 HISUN Pharmaceutical
11.5.1 HISUN Pharmaceutical Company Details
11.5.2 Company Business Overview
11.5.3 HISUN Pharmaceutical Carbapenem Sales, Revenue and Gross Margin (2014-2019)
11.5.4 HISUN Pharmaceutical Carbapenem Products Offered
11.5.5 HISUN Pharmaceutical Recent Development
11.6 Haibin Pharmaceutical
11.6.1 Haibin Pharmaceutical Company Details
11.6.2 Company Business Overview
11.6.3 Haibin Pharmaceutical Carbapenem Sales, Revenue and Gross Margin (2014-2019)
11.6.4 Haibin Pharmaceutical Carbapenem Products Offered
11.6.5 Haibin Pharmaceutical Recent Development
11.7 United Lab
11.7.1 United Lab Company Details
11.7.2 Company Business Overview
11.7.3 United Lab Carbapenem Sales, Revenue and Gross Margin (2014-2019)
11.7.4 United Lab Carbapenem Products Offered
11.7.5 United Lab Recent Development
12 Future Forecast
12.1 Carbapenem Market Forecast by Regions
12.1.1 Global Carbapenem Sales Forecast by Regions 2019-2025
12.1.2 Global Carbapenem Revenue Forecast by Regions 2019-2025
12.2 Carbapenem Market Forecast by Type
12.2.1 Global Carbapenem Sales Forecast by Type 2019-2025
12.2.2 Global Carbapenem Revenue Forecast by Type 2019-2025
12.3 Carbapenem Market Forecast by Application
12.4 North America Carbapenem Forecast
12.5 Europe Carbapenem Forecast
12.6 Asia Pacific Carbapenem Forecast
12.7 Central & South America Carbapenem Forecast
12.8 Middle East and Africa Carbapenem Forecast
13 Market Opportunities, Challenges, Risks and Influences Factors Analysis
13.1 Market Opportunities and Drivers
13.2 Market Challenges
13.3 Market Risks/Restraints
13.4 Macroscopic Indicators
14 Value Chain and Sales Channels Analysis
14.1 Value Chain Analysis
14.2 Carbapenem Customers
14.3 Sales Channels Analysis
14.3.1 Sales Channels
14.3.2 Distributors
15 Research Findings and Conclusion
16 Appendix
16.1 Research Methodology
16.1.1 Methodology/Research Approach
16.1.2 Data Source
16.2 Author Details
16.3 Disclaimer
List of Table
List of Tables and Figures
Figure Carbapenem Product Picture
Table Carbapenem Market Segments
Table Key Manufacturers Carbapenem Covered
Table Global Carbapenem Market Size Growth Rate by Type 2019-2025 (MT) & (Million US$)
Figure Global Carbapenem Sales Market Share by Type in 2018 & 2025
Figure Meropenem Product Picture
Table Major Manufacturers of Meropenem
Figure Doripenem Product Picture
Table Major Manufacturers of Doripenem
Figure Imipenem Product Picture
Table Major Manufacturers of Imipenem
Figure Panipenem Product Picture
Table Major Manufacturers of Panipenem
Figure Others Product Picture
Table Major Manufacturers of Others
Table Global Carbapenem Market Size Growth Rate by Application 2019-2025 (MT)
Figure Global Carbapenem 4900 Sales Market Share by Application in 2018
Figure Hosptials
Figure Clinics
Figure Others
Figure Carbapenem Report Years Considered
Figure Global Carbapenem Market Size 2014-2025 (Million US$)
Figure Global Carbapenem Sales 2014-2025 (MT)
Table Global Carbapenem Market Size by Regions 2014-2019 (MT) & (Million US$)
Table Global Carbapenem Sales by Regions 2014-2019 (MT)
Table Global Carbapenem Sales Market Share by Regions 2014-2019
Figure Global Carbapenem Sales Market Share by Regions 2014-2019
Figure 2018 Global Carbapenem Sales Market Share by Regions
Table Global Carbapenem Revenue by Regions 2014-2019 (Million US$)
Table Global Carbapenem Revenue Market Share by Regions 2014-2019
Figure Global Carbapenem Revenue Market Share by Regions 2014-2019
Figure 2018 Global Carbapenem Revenue Market Share by Regions
Table Global Carbapenem Sales by Manufacturers (2014-2019) (MT)
Table Global Carbapenem Sales Share by Manufacturers (2014-2019)
Figure Global Carbapenem Sales Share by Manufacturers in 2018
Table Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table Carbapenem Revenue by Manufacturers (2014-2019) (Million USD)
Table Carbapenem Revenue Share by Manufacturers (2014-2019)
Figure Carbapenem Value Share by Manufacturers in 2018
Table Key Manufacturers Carbapenem Price (2014-2019) (USD/Kg)
Table Carbapenem Manufacturers Manufacturing Base Distribution and Headquarters
Table Manufacturers Carbapenem Product Type
Table Date of International Manufacturers Enter into Carbapenem Market
Table Manufacturers Mergers & Acquisitions, Expansion Plans
Table Global Carbapenem Sales by Type (2014-2019) (MT)
Table Global Carbapenem Sales Share by Type (2014-2019)
Figure Global Carbapenem Sales Market Share by Type (2014-2019)
Figure Global Carbapenem Sales Market Share by Type in 2018
Table Global Carbapenem Revenue by Type (2014-2019) (Million US$)
Table Global Carbapenem Revenue Share by Type (2014-2019)
Figure Global Carbapenem Revenue Market Share by Type (2014-2019)
Figure Global Carbapenem Revenue Market Share by Type in 2018
Table Carbapenem Price by Type 2014-2019 (USD/Kg)
Table Global Carbapenem Sales by Application (2014-2019) (MT)
Table Global Carbapenem Sales Share by Application (2014-2019)
Figure Global Sales Carbapenem Market Share by Application (2014-2019)
Figure Global Sales Carbapenem Market Share by Application in 2018
Figure North America Carbapenem Sales Growth Rate 2014-2019 (MT)
Figure North America Carbapenem Revenue Growth Rate 2014-2019 (Million US$)
Table North America Carbapenem Sales by Country (2014-2019) (MT)
Table North America Carbapenem Sales Market Share by Country (2014-2019)
Figure 2018 North America Carbapenem Sales Market Share by Country
Table North America Carbapenem Revenue by Country (2014-2019) (Million US$)
Table North America Carbapenem Revenue Market Share by Country (2014-2019)
Figure 2018 North America Carbapenem Revenue Market Share by Country
Figure United States Carbapenem Sales Growth Rate (2014-2019) (MT)
Figure United States Carbapenem Revenue Growth Rate (2014-2019) (Million US$)
Figure Canada Carbapenem Sales Growth Rate (2014-2019) (MT)
Figure Canada Carbapenem Revenue Growth Rate (2014-2019) (Million US$)
Figure Mexico Carbapenem Sales Growth Rate (2014-2019) (MT)
Figure Mexico Carbapenem Revenue Growth Rate (2014-2019) (Million US$)
Table North America Carbapenem Sales by Type (2014-2019) (MT)
Table North America Carbapenem Sales Market Share by Type (2014-2019)
Figure 2018 North America Carbapenem Market Share by Type
Table North America Carbapenem Sales by Application (2014-2019) (MT)
Table North America Carbapenem Sales Market Share by Application (2014-2019)
Figure 2018 North America Carbapenem Market Share by Application
Figure Europe Carbapenem Sales Growth Rate 2014-2019 (MT)
Figure Europe Carbapenem Revenue Growth Rate 2014-2019 (Million US$)
Table Europe Carbapenem Sales by Country (2014-2019) (MT)
Table Europe Carbapenem Sales Market Share by Country (2014-2019)
Figure 2018 Europe Carbapenem Sales Market Share by Country
Table Europe Carbapenem Revenue by Country (2014-2019) (Million US$)
Table Europe Carbapenem Revenue Market Share by Country (2014-2019)
Figure 2018 Europe Carbapenem Revenue Market Share by Country
Figure Germany Carbapenem Sales Growth Rate (2014-2019) (MT)
Figure Germany Carbapenem Revenue Growth Rate (2014-2019) (Million US$)
Figure France Carbapenem Sales Growth Rate (2014-2019) (MT)
Figure France Carbapenem Revenue Growth Rate (2014-2019) (Million US$)
Figure UK Carbapenem Sales Growth Rate (2014-2019) (MT)
Figure UK Carbapenem Revenue Growth Rate (2014-2019) (Million US$)
Figure Italy Carbapenem Sales Growth Rate (2014-2019) (MT)
Figure Italy Carbapenem Revenue Growth Rate (2014-2019) (Million US$)
Figure Russia Carbapenem Sales Growth Rate (2014-2019) (MT)
Figure Russia Carbapenem Revenue Growth Rate (2014-2019) (Million US$)
Table Europe Carbapenem Sales by Type (2014-2019) (MT)
Table Europe Carbapenem Sales Market Share by Type (2014-2019)
Figure 2018 Europe Carbapenem Market Share by Type
Table Europe Carbapenem Sales by Application (2014-2019) (MT)
Table Europe Carbapenem Sales Market Share by Application (2014-2019)
Figure 2018 Europe Carbapenem Market Share by Application
Figure Asia Pacific Carbapenem Sales Growth Rate 2014-2019 (MT)
Figure Asia Pacific Carbapenem Revenue Growth Rate 2014-2019 (Million US$)
Table Asia Pacific Carbapenem Sales by Region (2014-2019) (MT)
Table Asia Pacific Carbapenem Sales Market Share by Region (2014-2019)
Figure 2018 Asia Pacific Carbapenem Sales Market Share by Region
Table Asia Pacific Carbapenem Revenue by Region (2014-2019) (Million US$)
Table Asia Pacific Carbapenem Revenue Market Share by Region (2014-2019)
Figure 2018 Asia Pacific Carbapenem Revenue Market Share by Country
Figure China Carbapenem Sales Growth Rate (2014-2019) (MT)
Figure China Carbapenem Revenue Growth Rate (2014-2019) (Million US$)
Figure Japan Carbapenem Sales Growth Rate (2014-2019) (MT)
Figure Japan Carbapenem Revenue Growth Rate (2014-2019) (Million US$)
Figure South Korea Carbapenem Sales Growth Rate (2014-2019) (MT)
Figure South Korea Carbapenem Revenue Growth Rate (2014-2019) (Million US$)
Figure India Carbapenem Sales Growth Rate (2014-2019) (MT)
Figure India Carbapenem Revenue Growth Rate (2014-2019) (Million US$)
Figure Australia Carbapenem Sales Growth Rate (2014-2019) (MT)
Figure Australia Carbapenem Revenue Growth Rate (2014-2019) (Million US$)
Figure Indonesia Carbapenem Sales Growth Rate (2014-2019) (MT)
Figure Indonesia Carbapenem Revenue Growth Rate (2014-2019) (Million US$)
Figure Thailand Carbapenem Sales Growth Rate (2014-2019) (MT)
Figure Thailand Carbapenem Revenue Growth Rate (2014-2019) (Million US$)
Figure Malaysia Carbapenem Sales Growth Rate (2014-2019) (MT)
Figure Malaysia Carbapenem Revenue Growth Rate (2014-2019) (Million US$)
Figure Philippines Carbapenem Sales Growth Rate (2014-2019) (MT)
Figure Philippines Carbapenem Revenue Growth Rate (2014-2019) (Million US$)
Figure Vietnam Carbapenem Sales Growth Rate (2014-2019) (MT)
Figure Vietnam Carbapenem Revenue Growth Rate (2014-2019) (Million US$)
Table Asia Pacific Carbapenem Sales by Type (2014-2019) (MT)
Table Asia Pacific Carbapenem Sales Market Share by Type (2014-2019)
Figure 2018 Asia Pacific Carbapenem Market Share by Type
Table Asia Pacific Carbapenem Sales by Application (2014-2019) (MT)
Table Asia Pacific Carbapenem Sales Market Share by Application (2014-2019)
Figure 2018 Asia Pacific Carbapenem Market Share by Application
Figure Central & South America Carbapenem Sales Growth Rate 2014-2019 (MT)
Figure Central & South America Carbapenem Revenue Growth Rate 2014-2019 (Million US$)
Table Central & South America Carbapenem Sales by Country (2014-2019) (MT)
Table Central & South America Carbapenem Sales Market Share by Country (2014-2019)
Figure 2018 Central & South America Carbapenem Sales Market Share by Country
Table Central & South America Carbapenem Revenue by Country (2014-2019) (Million US$)
Table Central & South America Carbapenem Revenue Market Share by Country (2014-2019)
Figure 2018 Central & South America Carbapenem Revenue Market Share by Country
Figure Brazil Carbapenem Sales Growth Rate (2014-2019) (MT)
Figure Brazil Carbapenem Revenue Growth Rate (2014-2019) (Million US$)
Table Central & South America Carbapenem Sales by Type (2014-2019) (MT)
Table Central & South America Carbapenem Sales Market Share by Type (2014-2019)
Figure 2018 Central & South America Carbapenem Market Share by Type
Table Central & South America Carbapenem Sales by Application (2014-2019) (MT)
Table Central & South America Carbapenem Sales Market Share by Application (2014-2019)
Figure 2018 Central & South America Carbapenem Market Share by Application
Figure Middle East and Africa Carbapenem Sales Growth Rate 2014-2019 (MT)
Figure Middle East and Africa Carbapenem Revenue Growth Rate 2014-2019 (Million US$)
Table Middle East and Africa Carbapenem Sales by Country (2014-2019) (MT)
Table Middle East and Africa Carbapenem Sales Market Share by Country (2014-2019)
Figure 2018 Middle East and Africa Carbapenem Sales Market Share by Country
Table Middle East and Africa Carbapenem Revenue by Country (2014-2019) (Million US$)
Table Middle East and Africa Carbapenem Revenue Market Share by Country (2014-2019)
Figure 2018 Middle East and Africa Carbapenem Revenue Market Share by Country
Figure Turkey Carbapenem Sales Growth Rate (2014-2019) (MT)
Figure Turkey Carbapenem Revenue Growth Rate (2014-2019) (Million US$)
Figure GCC Countries Carbapenem Sales Growth Rate (2014-2019) (MT)
Figure GCC Countries Carbapenem Revenue Growth Rate (2014-2019) (Million US$)
Figure Egypt Carbapenem Sales Growth Rate (2014-2019) (MT)
Figure Egypt Carbapenem Revenue Growth Rate (2014-2019) (Million US$)
Figure South Africa Carbapenem Sales Growth Rate (2014-2019) (MT)
Figure South Africa Carbapenem Revenue Growth Rate (2014-2019) (Million US$)
Table Middle East and Africa Carbapenem Sales by Type (2014-2019) (MT)
Table Middle East and Africa Carbapenem Sales Market Share by Type (2014-2019)
Figure 2018 Middle East and Africa Carbapenem Market Share by Type
Table Middle East and Africa Carbapenem Sales by Application (2014-2019) (MT)
Table Middle East and Africa Carbapenem Sales Market Share by Application (2014-2019)
Figure 2018 Middle East and Africa Carbapenem Market Share by Application
Table Pfizer Company Details
Table Pfizer Carbapenem Sales (MT), Revenue (Million USD), Price (USD/Kg) and Gross Margin (2014-2019)
Table Pfizer Recent Development
Table Savior Lifetec Company Details
Table Savior Lifetec Carbapenem Sales (MT), Revenue (Million USD), Price (USD/Kg) and Gross Margin (2014-2019)
Table Savior Lifetec Recent Development
Table Sun Pharmaceutical Industries Company Details
Table Sun Pharmaceutical Industries Carbapenem Sales (MT), Revenue (Million USD), Price (USD/Kg) and Gross Margin (2014-2019)
Table Sun Pharmaceutical Industries Recent Development
Table Kopran Company Details
Table Kopran Carbapenem Sales (MT), Revenue (Million USD), Price (USD/Kg) and Gross Margin (2014-2019)
Table Kopran Recent Development
Table HISUN Pharmaceutical Company Details
Table HISUN Pharmaceutical Carbapenem Sales (MT), Revenue (Million USD), Price (USD/Kg) and Gross Margin (2014-2019)
Table HISUN Pharmaceutical Recent Development
Table Haibin Pharmaceutical Company Details
Table Haibin Pharmaceutical Carbapenem Sales (MT), Revenue (Million USD), Price (USD/Kg) and Gross Margin (2014-2019)
Table Haibin Pharmaceutical Recent Development
Table United Lab Company Details
Table United Lab Carbapenem Sales (MT), Revenue (Million USD), Price (USD/Kg) and Gross Margin (2014-2019)
Table United Lab Recent Development
Table Global Carbapenem Sales Forecast by Regions 2019-2025 (MT)
Table Global Carbapenem Sales Market Share Forecast by Regions 2019-2025
Table Global Carbapenem Revenue Forecast by Regions 2019-2025 (Million US$)
Table Global Carbapenem Revenue Market Share Forecast by Regions 2019-2025
Table Global Carbapenem Sales Forecast by Type 2019-2025 (MT)
Table Global Carbapenem Sales Market Share Forecast by Type 2019-2025
Table Global Carbapenem Revenue Forecast by Type 2019-2025 (Million US$)
Table Global Carbapenem Revenue Market Share Forecast by Type 2019-2025
Table Global Carbapenem Sales Forecast by Application 2019-2025 (MT)
Table Global Carbapenem Sales Market Share Forecast by Application 2019-2025
Figure North America Carbapenem Sales Growth Rate Forecast (2019-2025) (MT)
Figure North America Carbapenem Revenue Growth Rate Forecast (2019-2025) (Million US$)
Figure Europe Carbapenem Sales Growth Rate Forecast (2019-2025) (MT)
Figure Europe Carbapenem Revenue Growth Rate Forecast (2019-2025) (Million US$)
Figure Asia Pacific Carbapenem Sales Growth Rate Forecast (2019-2025) (MT)
Figure Asia Pacific Carbapenem Revenue Growth Rate Forecast (2019-2025) (Million US$)
Figure Central & South America Carbapenem Sales Growth Rate Forecast (2019-2025) (MT)
Figure Central & South America Carbapenem Revenue Growth Rate Forecast (2019-2025) (Million US$)
Figure Middle East and Africa Carbapenem Sales Growth Rate Forecast (2019-2025) (MT)
Figure Middle East and Africa Carbapenem Revenue Growth Rate Forecast (2019-2025) (Million US$)
Table Key Opportunities and Drivers: Impact Analysis (2019-2025)
Table Key Challenges
Table Market Risks
Figure Porter's Five Forces Analysis
Table Carbapenem Value Chain
Table Carbapenem Customers List
Figure Channels of Distribution
Table Carbapenem Distributors List
Figure Distributors Profiles
Table Research Programs/Design for This Report
Figure Bottom-up and Top-down Approaches for This Report
Figure Data Triangulation
Figure Key Executives Interviewed
Table Key Data Information from Secondary Sources
Table Key Data Information from Primary Sources
-
U.S.:
-
U.K. :
-
AUS. :
-
INDIA :
